documents: FDA-2020-D-1137-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1137-0002 FDA FDA-2020-D-1137 Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency Guidance for Industry Other Guidance 2020-04-03T04:00:00Z 2020 4 2020-04-03T04:00:00Z   2024-11-06T23:35:19Z   1 0 090000648448551c

Links from other tables